152 related articles for article (PubMed ID: 28442024)
1. Intracytoplasmic oxidative stress reverses epigenetic modifications in polycystic ovary syndrome.
Eini F; Novin MG; Joharchi K; Hosseini A; Nazarian H; Piryaei A; Bidadkosh A
Reprod Fertil Dev; 2017 Nov; 29(12):2313-2323. PubMed ID: 28442024
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone reduces intracytoplasmic oxidative stress and improves epigenetic modification in polycystic ovary syndrome mice oocytes, during in-vitro maturation.
Eini F; Bidadkosh A; Nazarian H; Piryaei A; Ghaffari Novin M; Joharchi K
Mol Reprod Dev; 2019 Aug; 86(8):1053-1066. PubMed ID: 31209968
[TBL] [Abstract][Full Text] [Related]
3. Potential of Auraptene in Improvement of Oocyte Maturation, Fertilization Rate, and Inflammation in Polycystic Ovary Syndrome Mouse Model.
Abizadeh M; Novin MG; Amidi F; Ziaei SA; Abdollahifar MA; Nazarian H
Reprod Sci; 2020 Sep; 27(9):1742-1751. PubMed ID: 32124396
[TBL] [Abstract][Full Text] [Related]
4. Metformin improves epigenetic modification involved in oocyte growth and embryo development in polycystic ovary syndrome mice model.
Amani Abkenari S; Safdarian L; Amidi F; Hosseini A; Aryanpour R; Salahi E; Sobhani A
Mol Reprod Dev; 2021 Dec; 88(12):817-829. PubMed ID: 34658106
[TBL] [Abstract][Full Text] [Related]
5. Impaired oocyte quality induced by dehydroepiandrosterone is partially rescued by metformin treatment.
Huang Y; Yu Y; Gao J; Li R; Zhang C; Zhao H; Zhao Y; Qiao J
PLoS One; 2015; 10(3):e0122370. PubMed ID: 25811995
[TBL] [Abstract][Full Text] [Related]
6. High level of C-type natriuretic peptide induced by hyperandrogen-mediated anovulation in polycystic ovary syndrome mice.
Wang X; Wang H; Liu W; Zhang Z; Zhang Y; Zhang W; Chen Z; Xia G; Wang C
Clin Sci (Lond); 2018 Apr; 132(7):759-776. PubMed ID: 29535265
[TBL] [Abstract][Full Text] [Related]
7. Oocyte quality is impaired in a hyperandrogenic PCOS mouse model by increased Foxo1 expression.
Danfeng D; Ke D; Dengxuan F; Xuelian L; Congjian X
Reprod Biol; 2023 Dec; 23(4):100812. PubMed ID: 37806115
[TBL] [Abstract][Full Text] [Related]
8. Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.
Zhu JQ; Zhu L; Liang XW; Xing FQ; Schatten H; Sun QY
Mol Hum Reprod; 2010 Apr; 16(4):260-6. PubMed ID: 19828691
[TBL] [Abstract][Full Text] [Related]
9. Ovarian Metabolic activity in Dehydroepiandrosterone-Induced Polycystic Ovary in Wistar rats Treated with Aspirin.
Olaniyan OT; Bamidele O; Uche S; Femi A; Ayobami D; Ayoola O; Builders M; Mali PC
JBRA Assist Reprod; 2020 Jan; 24(1):41-54. PubMed ID: 31608617
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of Gpr1 improves steroid hormone abnormality in hyperandrogenized mice.
Yang YL; Sun LF; Yu Y; Xiao TX; Wang BB; Ren PG; Tang HR; Zhang JV
Reprod Biol Endocrinol; 2018 May; 16(1):50. PubMed ID: 29793502
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.
Tessaro I; Modina SC; Franciosi F; Sivelli G; Terzaghi L; Lodde V; Luciano AM
J Ovarian Res; 2015 Oct; 8():64. PubMed ID: 26437930
[TBL] [Abstract][Full Text] [Related]
12. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
13. HDAC5 inhibits ovarian angiogenesis in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.
Wang Y; Wang Y; Chen Y; Gao Q; Hou L; Feng X
Folia Histochem Cytobiol; 2022; 60(3):260-270. PubMed ID: 36124413
[TBL] [Abstract][Full Text] [Related]
14. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.
Lai H; Jia X; Yu Q; Zhang C; Qiao J; Guan Y; Kang J
Biol Reprod; 2014 Nov; 91(5):127. PubMed ID: 25100714
[TBL] [Abstract][Full Text] [Related]
15. Effects of n-3 PUFA supplementation on oocyte in vitro maturation in mice with polycystic ovary syndrome.
Ma R; Wang S; Xue M; Zhang H; He Z; Jueraitetibaike K; Ge X; Chen L; Yao B
J Ovarian Res; 2023 Apr; 16(1):87. PubMed ID: 37120599
[TBL] [Abstract][Full Text] [Related]
16. Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats.
Mesbah F; Moslem M; Vojdani Z; Mirkhani H
J Ovarian Res; 2015 Nov; 8():74. PubMed ID: 26577050
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M
Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112
[TBL] [Abstract][Full Text] [Related]
18. Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats.
Henmi H; Endo T; Nagasawa K; Hayashi T; Chida M; Akutagawa N; Iwasaki M; Kitajima Y; Kiya T; Nishikawa A; Manase K; Kudo R
Biol Reprod; 2001 Jan; 64(1):157-62. PubMed ID: 11133670
[TBL] [Abstract][Full Text] [Related]
19. Systemic adiponectin treatment reverses polycystic ovary syndrome-like features in an animal model.
Singh A; Bora P; Krishna A
Reprod Fertil Dev; 2018 Mar; 30(4):571-584. PubMed ID: 28911368
[TBL] [Abstract][Full Text] [Related]
20. Effects of vitamin D on ovary in DHEA-treated PCOS rat model: A light and electron microscopic study.
Çelik LS; Kuyucu Y; Yenilmez ED; Tuli A; Dağlıoğlu K; Mete UÖ
Ultrastruct Pathol; 2018; 42(1):55-64. PubMed ID: 29192811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
